| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,344 | 755 | 3,546 | 3,121 | | Cost of Revenue | 1,041 | 648 | 2,944 | 3,232 | | | Gross Profit | 303 | 107 | 602 | (111) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 437 | 467 | 440 | 553 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (134) | (360) | 163 | (664) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (5,150) | (1,266) | 1,922 | 628 | | Earnings Before Interest And Taxes | (5,284) | (1,626) | 2,085 | (36) | | Interest Expense | 52 | 50 | 47 | 52 | | Income Before Tax | (5,336) | (1,676) | 2,039 | (88) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,336) | (1,676) | 2,039 | (88) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,336) | (1,676) | 2,039 | (88) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,336) | ($1,676) | $2,039 | ($88) |
|
0.05% Nasdaq 
0.21%
Income Statement
